๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-05-21

Nectero EAST System Clinical Study (NCT06001918)

Randomized Controlled Clinical Trial (RCT) of the Nectero EAST System for Small to Mid-Sized Abdominal Aortic Aneurysms (AAA) StaBiLization: Evaluation of Efficacy.

๐ŸŸข Recruiting Phase2 / Phase3 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: Nectero Medical, Inc.

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The purpose of this randomized clinical trial is to treat patients with small to mid-sized abdominal aortic aneurysms (AAA), maximum diameter of 3.5 cm to 5.0 cm, using a locally delivered, single-dose endovascular treatment. The main question the study aims to answer is to demonstrate efficacy of the product for stabilization of these small to mid-sized AAA.The study will compare the treatment group to the typical standard of care for these patients, surveillance. All subjects will be followed at designated intervals at 30/60 days, 6, 12, 18 and 24 months with continued follow-up annually for up to 5 years.

Who can join: Review the eligibility criteria below.

Location: Honor Health Scottsdale Shea Medical Center โ€” Scottsdale, Arizona

Age range: 21 Years to 85 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (39 Sites)

Showing the first 25 of 39 sites.

  • Honor Health Scottsdale Shea Medical Center โ€” Scottsdale, Arizona
  • University of Colorado โ€” Aurora, Colorado
  • Medstar Washington Hospital Center โ€” Washington D.C., District of Columbia
  • Prime Vascular Institute โ€” Delray Beach, Florida
  • Medical College of Georgia โ€” Augusta, Georgia
  • University of Chicago โ€” Chicago, Illinois
  • MaineMed Vascular Surgery โ€” Scarborough, Maine
  • Massachusetts General Hospital โ€” Boston, Massachusetts
  • Beth Israel Deaconess Medical Center โ€” Boston, Massachusetts
  • University of Massachusetts โ€” Worcester, Massachusetts
  • Beaumont Health โ€” Royal Oak, Michigan
  • Washington University School of Medicine โ€” St Louis, Missouri
  • University of Nebraska Medical Center โ€” Omaha, Nebraska
  • Dartmouth Hitchcock Medical Center โ€” Lebanon, New Hampshire
  • University of Rochester โ€” Rochester, New York
  • Stony Brook Medicine โ€” Stony Brook, New York
  • Duke University Medical Center โ€” Durham, North Carolina
  • The Christ Hospital โ€” Cincinnati, Ohio
  • University Hospitals Cleveland โ€” Cleveland, Ohio
  • Cleveland Clinic โ€” Cleveland, Ohio
  • The Ohio State University Wexner Medical Center โ€” Columbus, Ohio
  • Ohio Health Riverside โ€” Columbus, Ohio
  • Oklahoma Heart Institute โ€” Tulsa, Oklahoma
  • Portland VA Medical Center โ€” Portland, Oregon
  • St. Luke's University Health Network โ€” Bethlehem, Pennsylvania

๐Ÿ“ž Contact the Study Coordinator

Phone: (866) 755-4744

Email: cknape@necteromedical.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—